Announce Date | 07/22/2025 |
EPS Normalized Actual | $1.91 (Beat by $0.05) |
EPS GAAP Actual | $1.91 (Beat by $0.05) |
Revenue Actual | $10.14B |
Revenue Surprise | Beat by $10140M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.76995 |
EPS GAAP Estimate | $1.76995 |
Revenue Estimate | $9.873749032B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 10.49 | 15.5 | 10.09352 | 10.83139 | 4 |
Dec 2028 | 9.90252 | 16.42 | 9.58572 | 10.19732 | 6 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.95 | 0.15005 | 10.14B | 6.63% | 152.75M |
FQ1 2025 (Mar 2025) | 1.72 | 1.72 | 9.301B | 5.46% | 9301M |
FQ4 2024 (Dec 2024) | 0 | 0 | 9.706B | 6.79% | 9706M |
FQ3 2024 (Sep 2024) | 1.98 | 1.98 | 9.911B | 7.77% | 9911M |
FQ2 2024 (Jun 2024) | 1.54 | 1.54 | 9.468B | 5.29% | 9468M |
FQ1 2024 (Mar 2024) | 1.38 | 1.38 | 8.793B | 8.8% | 8793M |
FQ4 2023 (Dec 2023) | 0 | 0 | 9.047B | 100% | 9047M |
FQ3 2023 (Sep 2023) | 1.32 | 1.32 | 9.141B | 100% | 9141M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.76995
Consensus Revenue Estimates
9.873749032B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.21394 | -- | 2.15653 | 2.25482 | 7 |
FQ3 2027 (Sep 2027) | 2.38519 | -- | 2.38519 | 2.38519 | 2 |
FQ2 2027 (Jun 2027) | 2.14351 | -- | 2.14351 | 2.14351 | 2 |
FQ1 2027 (Mar 2027) | 2.06834 | -- | 2.0147 | 2.10653 | 7 |
FQ4 2026 (Oct 2026) | 2.28548 | -- | 2.22019 | 2.32888 | 3 |
FQ3 2026 (Jul 2026) | 1.99928 | -- | 1.94217 | 2.03724 | 4 |
FQ2 2026 (Jun 2026) | 1.99928 | 2.46 | 1.95053 | 2.04669 | 4 |
FQ1 2026 (Mar 2026) | 1.69323 | -1.58 | 1.65194 | 1.73339 | 5 |
FQ4 2025 (Oct 2025) | 2.02343 | -- | 1.96563 | 2.06185 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 11.07B | -- | 10.85B | 11.23B | 5 |
FQ3 2027 (Sep 2027) | 11.74B | -- | 11.74B | 11.74B | 2 |
FQ2 2027 (Jun 2027) | 11.34B | -- | 11.34B | 11.34B | 2 |
FQ1 2027 (Mar 2027) | 10.58B | -- | 10.37B | 10.73B | 5 |
FQ4 2026 (Oct 2026) | 11.04B | -- | 10.8B | 11.2B | 4 |
FQ3 2026 (Jul 2026) | 10.63B | -- | 10.39B | 10.78B | 5 |
FQ2 2026 (Jun 2026) | 10.63B | 4.57 | 10.43B | 10.82B | 4 |
FQ1 2026 (Mar 2026) | 9.43B | 1.32 | 9.25B | 9.6B | 4 |
FQ4 2025 (Oct 2025) | 10.29B | 5.65 | 10.06B | 10.44B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
0
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.79995 | 1.95 | 0.15005 | 7.69% |
FQ1 2025 (Mar 2025) | 1.72 | 1.72 | 100% | |
FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Sep 2024) | 1.98 | 1.98 | 100% | |
FQ2 2024 (Jun 2024) | 1.54 | 1.54 | 100% | |
FQ1 2024 (Mar 2024) | 1.38 | 1.38 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 1.32 | 1.32 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $9.99B | $10.14B | $152.75M | 1.51% |
FQ1 2025 (Mar 2025) | $0B | $9.3B | $9301M | 100% |
FQ4 2024 (Dec 2024) | $0B | $9.71B | $9706M | 100% |
FQ3 2024 (Sep 2024) | $0B | $9.91B | $9911M | 100% |
FQ2 2024 (Jun 2024) | $0B | $9.47B | $9468M | 100% |
FQ1 2024 (Mar 2024) | $0B | $8.79B | $8793M | 100% |
FQ4 2023 (Dec 2023) | $0B | $9.05B | $9047M | 100% |
FQ3 2023 (Sep 2023) | $0B | $9.14B | $9141M | 100% |